Hypodermic Safety Syringe Designer, Maxxon, Inc., Listed as a Featured Company on the Internet Investment Super Site Stockprofiles.com.TULSA, Okla.--(BW HealthWire)--Sept. 25, 1997--The Center for Business Resources ("CFBR CFBR Conventional Fluidized Bed Reactor ") announced today that its client, Maxxon, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : MXON), has been selected for inclusion as a "Featured Company" on the Internet investment Super Site, http:\\www.stockprofiles.com . Stockprofiles.com currently receives over 400,000 viewers monthly that primarily consist of investment professionals and individual investors. Lou Andreana, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Stockprofiles.com stated: "We provide the story behind the symbol. This ability to offer information on companies, coupled with real time news, quotes, charts, and reputable third party research, clearly defines Stockprofiles.com as the one to imitate. We look for visitors to our site to continue to increase, specifically since these great features are totally free for our users." Todd Hickman, Executive Director of CFBR, stated: "Maxxon's inclusion in this Internet Super Site will significantly increase investor awareness Investor Awareness is knowledge the investment community has of a company. [1] It can be looked at like this: “Do investors know about your company?” If the answer is “yes,” then it could be said that the company has “good investor awareness” . We are extremely pleased and look forward to assisting Mr. Andreana's team with all information. We definitely feel that this inclusion will facilitate universal due diligence Research; analysis; your homework. This term has caught on in all industries, because it sounds so "wired." Who would want to do analysis or research when they can do due diligence. See wired. accessibility to Maxxon's company information." Maxxon, Inc. is an innovative medical technologies company offering cutting-edge solutions. Maxxon's primary focus is the manufacturing and distribution of its patented, disposable safety syringe that automatically retracts the needle into the plunger after use, thereby eliminating the risk of accidental "needlestick" injuries, especially to medical service and nursing personnel. The Maxxon Safety Syringe(TM), which meets all OSHA OSHA n. Occupational Safety and Health Administration, a branch of the US Department of Labor responsible for establishing and enforcing safety and health standards in the workplace. standards, is expected to save hundreds of lives annually. According to estimates of project engineers, the Maxxon Safety Syringe(TM) can be produced to be competitive with non-safety syringes currently in use. The Company plans to market the syringe internationally, which accounts for 80% of the total market for syringes, while awaiting FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for distribution in the U.S. The world marketplace is estimated to be 15 billion units annually. For additional information call or visit us at our website at http:\\www.stockprofiles.com/mxon . CONTACT: Maxxon, Inc., Tulsa, Okla. William Robinson, V.P., Investor Relations Investor relations The process by which the corporation communicates with its investors. , 888/492-1257 or The Center for Business Resources, Houston Todd Hickman, Executive Director, 281/370-2544 or Stockprofiles.com, Ft. Lauderdale, Fla. Lou Andreana, President, 954/564-2051 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion